|
[1]
|
Perkins, D.O., Jeffries, C.D., Jarskog, L.F., et al. (2013) Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of Risk Loci with Shared Effects on Five Major Psychiatric Disorders: A Genome-Wide Analysis. Lancet, 381, 1371-1379.
|
|
[2]
|
Schreiber, R. and Newman-Tancredi, A. (2014) Improving Cognition in Schizophrenia with Antipsychotics that Elicit Neurogenesis through 5-HT(1A) Receptor Activation. Neurobiology of Learning and Memory, 110, 72-80.
|
|
[3]
|
Sandoval, J., Díaz-Lagares, A., Salgado, R., et al. (2015) MicroRNA Expression Profiling and DNA Methylation Signature Forderegulated MicroRNA in Cutaneous T-Cell Lymphom. Journal of Investigative Dermatology, 135, 1128-1137.
|
|
[4]
|
Pedroza-Torres, A., López-Urrutia, E., García-Castillo, V., et al. (2014) MicroRNAs in Cervical Cancer: Evidences for a miRNA Profile Deregulated by HPV and Its Impact on Radio-Resistance. Molecules, 19, 6263-6281. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Shi, Y., Zhao, X., Hsieh, J., et al. (2010) MicroRNA Regulation of Neural Stem Cells and Neurogenesis. Journal of Neuroscience, 30, 14931-14936.
|
|
[6]
|
Lang, M.F. and Shi, Y. (2012) Dynamic Roles of MicroRNAs in Neurogenesis. Frontiers in Neuroscience, 6, 71.
|
|
[7]
|
Miller, B.H., Zeier, Z., Xi, L., et al. (2012) MicroRNA-132 Dysregulation in Schizophrenia Has Implications for Both Neurodevelopment and Adult Brain Function. Proceedings of the National Academy of Sciences of the United States of America, 109, 3125-3130.
|
|
[8]
|
Santarelli, D.M., Beveridge, N.J., Tooney, P.A., et al. (2011) Upregulation of Dicer and MicroRNA Expression in the Dorsolateral Prefrontal Cortex Brodmann Area 46 in Schizophrenia. Biological Psychiatry, 69, 180-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wong, J., Duncan, C.E., Beveridge, N.J., et al. (2013) Ex-pression of NPAS3 in the Human Cortex and Evidence of Its Posttranscriptional Regulation by miR-17 During Devel-opment, with Implications for Schizophrenia. Schizophrenia Bulletin, 39, 396-406. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Lett, T.A., Chakavarty, M.M., Felsky, D., et al. (2013) The Ge-nome-Wide Supported MicroRNA-137 Variant Predicts Phenotypic Heterogeneity within Schizophrenia. Molecular Psychiatry, 18, 443-450.
|
|
[11]
|
Fujiwara, T., Uotani, K., Yoshida, A., et al. (2017) Clinical Significance of Circulating miR-25-3p as A Novel Diagnostic and Prognostic Biomarker in Osteosarcoma. Oncotarget, 8, 33375.
|
|
[12]
|
Sita-Lumsden, A.R., Leach, D., Zivi, A., et al. (2017) A Circulating miRNA Signature to Help Prognos-ticate at Prostate Cancer Diagnosis. Journal of Clinical Oncology, 35, 108.
|
|
[13]
|
Yokoi, A., Yoshioka, Y., Hirakawa, A., et al. (2017) A Combination of Circulating miRNAs for the Early Detection of Ovarian Cancer. Oncotarget, 8, 89-93.
|
|
[14]
|
Santangelo, A., Imbruce, P., Gardenghi, B.A., et al. (2018) A MicroRNA Signature from Serum Exosomes of Patients with Glioma as Complementary Diagnostic Biomarker. Journal of Neuro-Oncology, 136, 51.
|
|
[15]
|
Glinsky, Z.Z., Xi, L., et al. (2012) MicroRNA-132 Dysregulation in Schizophrenia Has Implications for Both Neurodevelopment and Adult Brain Function. Proceedings of the National Academy of Sciences of the United States of America, 109, 3125-3130.
|
|
[16]
|
Liu, B., Qu, J., Xu, F., et al. (2015) MiR-195 Suppresses Non-Small Cell Lung Cancer By-Targeting CHEK1. Oncotarget, 6, 9445-9456. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Libman-Sokolowska, M., Drozdowicz, E. and Nasierowski, T. (2015) BDNF as a Biomarker in the Course and Treatment of Schizophrenia. Psychiatria Polska, 49, 1149-1158. [Google Scholar] [CrossRef]
|
|
[18]
|
Sun, X.Y., Zhang, J., Niu, W., et al. (2015) A Preliminary Analysis of microRNAas Potential Clinical Biomarker for Schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 168, 170-178. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lennertz, L., Quednow, B.B., Benninghoff, J., et al. (2011) Impact of TCF4 on the Genetics of Schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 261, S161-S165. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yan, J.J., Chang, Y., Zhang, Y.N., et al. (2017) miR-195 Inhibits Cell Proliferation via Targeting AEG-1 in Hepatocellular Carcinoma. Oncology Letters, 13, 3118-3126. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Sun, X.Y., Lu, J., Zhang, L., et al. (2015) Aberrant microRNA Expres-sion in Peripheral Plasma and Mononuclear Cells as Specific Blood-Based Biomarkers in Schizophrenia Patients. Journal of Clinical Neuroscience, 22, 570-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Chai, C., Song, L.J., Yang, B., et al. (2016) Circulating miR-199a-3p in Plasma and Its Potential Diagnostic and Prognostic Value in Glioma. European Review for Medical and Pharmacological Sciences, 20, 4885.
|
|
[23]
|
Chen, J., Yang, L., Wang, X., et al. (2017) Reduced Circulating mi-croRNA-203 Predicts Poor Prognosis for Glioblastoma. Cancer Biomark, 20, 521-526. [Google Scholar] [CrossRef]
|
|
[24]
|
Huang, Q., Wang, C.J., Hou, Z.M., et al. (2017) Serum microRNA-376 Family as Diagnostic and Prognostic Markers in Human Gliomas. Cancer Biomark, 19, 137-144. [Google Scholar] [CrossRef]
|
|
[25]
|
Tang, Y., Zhao, S., Wang, J., et al. (2017) Plasma miR-122 as a Po-tential Diagnostic and Prognostic Indicator in Human Glioma. Neurological Sciences, 38, 1087-1092. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Shi, W., Du, J., Qi, Y., et al. (2012) Aberrant Expression of Se-rum miRNAs in Schizophrenia. Journal of Psychiatric Research, 46, 198-204. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Liu, S., Yuan, Y.B., Guan, L.L., et al. (2013) miRNA-365 and miRNA-520c-3p Respond to Risperidone Treatment in First-Episode Schizophrenia after a 1 Year Remission. Chinese Medical Journal, 126, 2676-2680.
|